|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chronic Heart Failure | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Heart Failure | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| allopurinol | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antioxidants | |||||
| Antirheumatic Agents | |||||
| Enzyme Inhibitors | |||||
| Free Radical Scavengers | |||||
| Gout Suppressants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Universita di Verona | |||||